Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Sanofi/Regeneron cholesterol drug reaches Phase III

May 29, 2012 Research and Development, Sales and Marketing Amgen, PCKS9, Regeneron, SAR236553, Sanofi

Sanofi and Regeneron’s anti-cholesterol drug has impressed in a mid-stage trial, and will now progress into Phase III.  The firms’ …
News

Lundbeck’s Alzheimer’s drug shows promise

May 29, 2012 Research and Development, Sales and Marketing Alzheimer's, Lundbeck

Lundbeck’s Alzheimer’s candidate Lu AE58054 has shown signs in a phase II study of helping patients’ mental activity. Sufferers receiving …
News
Pradaxa image

European OK for Pradaxa, but more details required

May 29, 2012 Research and Development, Sales and Marketing Boehringer, CHMP, EMA, Europe, Pradaxa

The European Medicines Agency says that Boehringher’s Pradaxa can stay on the market, but will need more safety information.  The …
News

Life bolsters its client services team with two additions

May 28, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Life Healthcare Communications has developed its client services team with two new appointments to further support the needs of its …
Appointment

Pfizer appoints two senior roles

May 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pfizer, Read

Pfizer has named Olivier Brandicourt as president and general manager of its Emerging Markets and Established Products Business Units, and …
Appointment

Boehringer’s COPD drug passes hurdle

May 23, 2012 Research and Development, Sales and Marketing Boehringer, COPD, Daxas, Relovair, Spiriva, olodaterol

Boehringer Ingelheim’s once-daily bronchodilator olodaterol has improved lung function versus placebo in a Phase II trial.  The manufacturer wants the …
News
Doctor laptop image

Medical education: pharma’s evolving relationship with healthcare professionals

May 23, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Conference, InPharm, MEP, medical education

There are at least two perspectives of what ‘Medical Education’ means, and certainly many definitions.For doctors and other healthcare professionals, …
Feature

AMRI announces president for AMRI Europe

May 23, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AMRI, AMRI Europe, CMO

Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe.  In this …
Appointment
oliver_leatham

MSI appoints new market access consultant

May 22, 2012 Business Services, Medical Communications, Research and Development, Sales and Marketing MSI Consultancy, appointment, market access

Strategic marketing firm The MSI Consultancy has appointed Oliver Leatham as market access consultant. Oliver has a wide experience as …
Appointment

Pharma R&D model no help to developing countries

May 22, 2012 Research and Development, Sales and Marketing HIV, MSF, Médecins Sans Frontières, R&D

Médecins Sans Frontières is urging health ministers around the world to create an ‘R&D Convention’ to ensure that pharma helps …
News

UCB signs new epilepsy research pact with Imperial

May 21, 2012 Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy

UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
News

ICON makes two senior appointments

May 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRO, ICON, appointment

ICON has appointed Dr Susan Anton as director of epidemiology and risk management practice, and late phase and outcomes research. …
Appointment

GSK buys more of Theravance

May 18, 2012 Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …
News
screen_shot_2012-05-18_at_09

Teva re-elects Chairman of the Board

May 18, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frost, Teva

Teva has announced that its Board of Directors has unanimously voted to re-elect Dr Phillip Frost as Chairman of the …
Appointment

Medivir appoints commercial executive vice president

May 17, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Juserius, Medivir

Research-based speciality firm Medivir has appointed Henric Juserius to be the new head of the company’s commercial activities.  Juserius who …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026